Logo image of AMS

AMERICAN SHARED HOSPITAL SER (AMS) Stock Fundamental Analysis

USA - NYSEARCA:AMS - US0295951059 - Common Stock

2.3 USD
-0.13 (-5.35%)
Last: 10/10/2025, 9:10:00 PM
2.32 USD
+0.02 (+0.87%)
After Hours: 10/10/2025, 9:10:00 PM
Fundamental Rating

2

Taking everything into account, AMS scores 2 out of 10 in our fundamental rating. AMS was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AMS have multiple concerns. AMS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AMS had negative earnings in the past year.
AMS had a positive operating cash flow in the past year.
Of the past 5 years AMS 4 years were profitable.
Each year in the past 5 years AMS had a positive operating cash flow.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

AMS's Return On Assets of -3.84% is on the low side compared to the rest of the industry. AMS is outperformed by 63.37% of its industry peers.
AMS has a Return On Equity (-9.97%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.84%
ROE -9.97%
ROIC N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

In the last couple of years the Profit Margin of AMS has grown nicely.
In the last couple of years the Operating Margin of AMS has declined.
AMS's Gross Margin of 24.43% is in line compared to the rest of the industry. AMS outperforms 50.49% of its industry peers.
In the last couple of years the Gross Margin of AMS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AMS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.43%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

AMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMS has been increased compared to 1 year ago.
The number of shares outstanding for AMS has been increased compared to 5 years ago.
The debt/assets ratio for AMS is higher compared to a year ago.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that AMS is in the distress zone and has some risk of bankruptcy.
AMS has a Altman-Z score of 0.86. This is in the lower half of the industry: AMS underperforms 74.26% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that AMS is somewhat dependend on debt financing.
AMS has a Debt to Equity ratio (0.58) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC9.57%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

AMS has a Current Ratio of 1.17. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
AMS has a Current ratio of 1.17. This is in the lower half of the industry: AMS underperforms 63.37% of its industry peers.
A Quick Ratio of 1.17 indicates that AMS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, AMS is in line with its industry, outperforming 40.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

AMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -511.11%.
Measured over the past years, AMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.28% on average per year.
Looking at the last year, AMS shows a very strong growth in Revenue. The Revenue has grown by 26.63%.
AMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.58% yearly.
EPS 1Y (TTM)-511.11%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-300%
Revenue 1Y (TTM)26.63%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%0.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y49.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMS is valued cheaply inside the industry as 98.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.69
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (10/10/2025, 9:10:00 PM)

After market: 2.32 +0.02 (+0.87%)

2.3

-0.13 (-5.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners13.68%
Inst Owner Change0%
Ins Owners35.53%
Ins Owner Change4.75%
Market Cap14.97M
Analysts80
Price Target4.59 (99.57%)
Short Float %1.36%
Short Ratio1.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.21%
Min EPS beat(2)0.99%
Max EPS beat(2)43.42%
EPS beat(4)2
Avg EPS beat(4)-543.23%
Min EPS beat(4)-2080.2%
Max EPS beat(4)43.42%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-3.97%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)0.93%
Min Revenue beat(4)-7.97%
Max Revenue beat(4)16.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-173.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF N/A
P/OCF 5.2
P/B 0.61
P/tB 0.65
EV/EBITDA 3.69
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)0.44
OCFY19.21%
SpS4.49
BVpS3.76
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE -9.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.43%
FCFM N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 2.28
Cap/Depr 182.58%
Cap/Sales 39.16%
Interest Coverage N/A
Cash Conversion 46.15%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 0.86
F-Score4
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)86.06%
Cap/Depr(5y)59.68%
Cap/Sales(3y)19.8%
Cap/Sales(5y)14.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-511.11%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-300%
EPS Next Y49.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.63%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%0.21%
Revenue Next Year9.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.77%
EBIT growth 3Y-6.85%
EBIT growth 5Y-9.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-255.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.59%
OCF growth 3Y-70.14%
OCF growth 5Y-53.93%